Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4780037
Max Phase: Preclinical
Molecular Formula: C32H35N2NaO11
Molecular Weight: 624.64
Molecule Type: Unknown
Associated Items:
ID: ALA4780037
Max Phase: Preclinical
Molecular Formula: C32H35N2NaO11
Molecular Weight: 624.64
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(Cc1ccc(-c2ccc(O)cc2)cc1)NC[C@@H](O)[C@@H](O)[C@@H]1O[C@@](OCc2ccccc2)(C(=O)[O-])C[C@H](O)[C@H]1NC(=O)CO.[Na+]
Standard InChI: InChI=1S/C32H36N2O11.Na/c35-17-27(40)34-28-24(37)15-32(31(42)43,44-18-20-4-2-1-3-5-20)45-30(28)29(41)25(38)16-33-26(39)14-19-6-8-21(9-7-19)22-10-12-23(36)13-11-22;/h1-13,24-25,28-30,35-38,41H,14-18H2,(H,33,39)(H,34,40)(H,42,43);/q;+1/p-1/t24-,25+,28+,29+,30+,32+;/m0./s1
Standard InChI Key: BRWKDZYDGXKLQA-ZJKDNQKCSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 624.64 | Molecular Weight (Monoisotopic): 624.2319 | AlogP: 0.06 | #Rotatable Bonds: 13 |
Polar Surface Area: 215.11 | Molecular Species: ACID | HBA: 10 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.06 | CX Basic pKa: | CX LogP: 0.88 | CX LogD: -2.59 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.13 | Np Likeness Score: 0.48 |
1. Abdu-Allah HHM,Wu SC,Lin CH,Tseng YY. (2020) Design, synthesis and molecular docking study of α-triazolylsialosides as non-hydrolyzable and potent CD22 ligands., 208 [PMID:32942185] [10.1016/j.ejmech.2020.112707] |
Source(1):